The purposes of this study were to separate the effect of iron status
from the effect of acute iron intake on tissue retention of aluminum a
nd Ga-67 and to evaluate Ga-67 as a marker for aluminum. Anemic and co
ntrol rats were dosed by gavage with a citrate solution containing 20
mu Ci Ga-67 with no added aluminum and iron (Gavage Ga-67), with 0.8 m
mol aluminum (Gavage Al), with 0.8 mmol iron (Gavage Fe), or with both
0.8 mmol aluminum and 0.8 mmol iron (Gavage Fe and Al). After 24 h, a
nemic rats in the Gavage Al treatment had lower concentrations of alum
inum in their tibias, kidneys, and spleens than control rats in that t
reatment. In contrast, anemic rats dosed with only Ga-67 (Gavage Ga-67
treatment) had lower concentrations of Ga-67 in their tibias and kidn
eys, but greater concentrations of Ga-67 in their livers and spleens t
han control rats in that treatment. The single dose of iron had no eff
ect on tissue aluminum concentrations but depressed tissue Ga-67 conce
ntrations. All rats accumulated aluminum predominantly in bone and con
trol rats accumulated Ga-67 predominantly in bone, but anemic rats acc
umulated Ga-67 predominantly in liver. A major limitation of Ga-67 as
a marker for aluminum is its greater sensitivity than aluminum to iron
intake and status.